Literature DB >> 21477045

Substance use comorbidity among veterans with posttraumatic stress disorder and other psychiatric illness.

Ismene L Petrakis1, Robert Rosenheck, Rani Desai.   

Abstract

There is considerable concern about the emergence of significant substance abuse among younger veterans of war in the Middle East, especially among those with Posttraumatic Stress Disorder (PTSD), but little information exists on the magnitude of this problem. Using national administrative data from the Department of Veterans Affairs (VA) (n = 1,001,996), we examined rates of diagnosed substance use disorders in Veterans who served in Iraq and Afghanistan diagnosed with PTSD compared to other psychiatric disorders; and compared rates among veterans of other service eras. Of VA patients with a selected mental disorder, 21.0% had a comorbid substance diagnosis. Veterans who served in the post-Vietnam era (VET) (1973-1991) had the highest rates of comorbidity. Logistic regression models indicated that veterans with each selected psychiatric diagnosis were significantly more likely to be dually diagnosed in comparison to veterans with PTSD; post-Vietnam veterans were significantly more likely to be dually diagnosed than veterans from other eras. Bipolar disorder and schizophrenia are most strongly associated with dual diagnosis in OEF/OIF (Operation Enduring Freedom/Operation Iraqi Freedom) veterans. There are high rates of substance use disorders among veterans with mental illness. The highest rates of comorbidity occur among those with bipolar disorder and schizophrenia; and in post-VET veterans. © American Academy of Addiction Psychiatry.

Entities:  

Mesh:

Year:  2011        PMID: 21477045     DOI: 10.1111/j.1521-0391.2011.00126.x

Source DB:  PubMed          Journal:  Am J Addict        ISSN: 1055-0496


  43 in total

Review 1.  The epidemiology of substance use disorders in US Veterans: A systematic review and analysis of assessment methods.

Authors:  Chiao-Wen Lan; David A Fiellin; Declan T Barry; Kendall J Bryant; Adam J Gordon; E Jennifer Edelman; Julie R Gaither; Stephen A Maisto; Brandon D L Marshall
Journal:  Am J Addict       Date:  2015-12-22

2.  Posttraumatic Stress Disorder and Co-Occurring Substance Use Disorders: Advances in Assessment and Treatment.

Authors:  Jenna L McCauley; Therese Killeen; Daniel F Gros; Kathleen T Brady; Sudie E Back
Journal:  Clin Psychol (New York)       Date:  2012-09-01

Review 3.  Concurrent Treatment of Substance Use and PTSD.

Authors:  Julianne C Flanagan; Kristina J Korte; Therese K Killeen; Sudie E Back
Journal:  Curr Psychiatry Rep       Date:  2016-08       Impact factor: 5.285

Review 4.  Prevalence of, risk factors for, and consequences of posttraumatic stress disorder and other mental health problems in military populations deployed to Iraq and Afghanistan.

Authors:  Rajeev Ramchand; Rena Rudavsky; Sean Grant; Terri Tanielian; Lisa Jaycox
Journal:  Curr Psychiatry Rep       Date:  2015-05       Impact factor: 5.285

5.  DSM-5 personality traits discriminate between posttraumatic stress disorder and control groups.

Authors:  Lisa M James; Samantha L Anders; Carly K Peterson; Brian E Engdahl; Robert F Krueger; Apostolos P Georgopoulos
Journal:  Exp Brain Res       Date:  2015-04-11       Impact factor: 1.972

6.  Smoking, posttraumatic stress disorder, and alcohol use disorders in a nationally representative sample of Australian men and women.

Authors:  Miriam K Forbes; Julianne C Flanagan; Emma L Barrett; Erica Crome; Andrew J Baillie; Katherine L Mills; Maree Teesson
Journal:  Drug Alcohol Depend       Date:  2015-09-14       Impact factor: 4.492

7.  Iraq and Afghanistan veterans: national findings from VA residential treatment programs.

Authors:  Joan M Cook; Stephanie Dinnen; Casey O'Donnell; Nancy Bernardy; Robert Rosenheck; Rani Hoff
Journal:  Psychiatry       Date:  2013       Impact factor: 2.458

8.  Substance use disorders and PTSD: Examining substance use, PTSD symptoms, and dropout following imaginal exposure.

Authors:  Amber M Jarnecke; Nicholas P Allan; Christal L Badour; Julianne C Flanagan; Therese K Killeen; Sudie E Back
Journal:  Addict Behav       Date:  2018-10-16       Impact factor: 3.913

9.  Doxazosin for the treatment of co-occurring PTSD and alcohol use disorder: Design and methodology of a randomized controlled trial in military veterans.

Authors:  Sudie E Back; Julianne C Flanagan; Jennifer L Jones; Isabel Augur; Alan L Peterson; Stacey Young-McCaughan; David W Shirley; Aisling Henschel; Jane E Joseph; Brett T Litz; Allison K Hancock; John D Roache; Jim Mintz; Jennifer S Wachen; Terence M Keane; Kathleen T Brady
Journal:  Contemp Clin Trials       Date:  2018-08-24       Impact factor: 2.226

10.  Effects of intimate partner violence, PTSD, and alcohol use on cigarette smoking in a nationally representative sample.

Authors:  Julianne C Flanagan; Jahn K Hakes; Erin A McClure; Alexandra L Snead; Sudie E Back
Journal:  Am J Addict       Date:  2016-05-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.